Literature DB >> 34918285

Pathologic Classification of Ovarian Cancer.

Stephanie M McGregor1.   

Abstract

Optimal use of human tissue for research requires an understanding of basic pathologic principles. Given that the physical assessment of tissue must occur as part of standard clinical examination, it cannot be handled directly by investigators unless they are also a part of the care team. The purpose of this chapter is to provide an overview of the clinical analytic process, from initial gross handling to histologic examination by light microscopy and the use of ancillary studies, in order to provide context for samples that are used in research and to highlight specific considerations that are relevant for obtaining appropriate tissue for experimental purposes. Given that they comprise >95% of ovarian malignancies, there is an emphasis on epithelial tumors.
© 2022. The Author(s), under exclusive license to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Ovarian cancer; Pathologic classification

Mesh:

Year:  2022        PMID: 34918285     DOI: 10.1007/978-1-0716-1956-8_2

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  41 in total

1.  Comparative analysis of alternative and traditional immunohistochemical markers for the distinction of ovarian sertoli cell tumor from endometrioid tumors and carcinoid tumor: A study of 160 cases.

Authors:  Chengquan Zhao; Gary L Bratthauer; Ross Barner; Russell Vang
Journal:  Am J Surg Pathol       Date:  2007-02       Impact factor: 6.394

2.  The Fallopian Tube Origin and Primary Site Assignment in Extrauterine High-grade Serous Carcinoma: Findings of a Survey of Pathologists and Clinicians.

Authors:  W Glenn McCluggage; Lynn Hirschowitz; C Blake Gilks; Nafisa Wilkinson; Naveena Singh
Journal:  Int J Gynecol Pathol       Date:  2017-05       Impact factor: 2.762

Review 3.  A practical approach to immunohistochemical diagnosis of ovarian germ cell tumours and sex cord-stromal tumours.

Authors:  Joseph T Rabban; Charles J Zaloudek
Journal:  Histopathology       Date:  2013-01       Impact factor: 5.087

4.  Diagnosis of serous tubal intraepithelial carcinoma based on morphologic and immunohistochemical features: a reproducibility study.

Authors:  Kala Visvanathan; Russell Vang; Patricia Shaw; Amy Gross; Robert Soslow; Vinita Parkash; Ie-Ming Shih; Robert J Kurman
Journal:  Am J Surg Pathol       Date:  2011-12       Impact factor: 6.394

Review 5.  Ovarian carcinomas: at least five different diseases with distinct histological features and molecular genetics.

Authors:  Jaime Prat; Emanuela D'Angelo; Iñigo Espinosa
Journal:  Hum Pathol       Date:  2018-06-23       Impact factor: 3.466

6.  The Many Uses of p53 Immunohistochemistry in Gynecological Pathology: Proceedings of the ISGyP Companion Society Session at the 2020 USCAP Annual9 Meeting.

Authors:  Martin Köbel; Eun Young Kang
Journal:  Int J Gynecol Pathol       Date:  2021-01       Impact factor: 2.762

7.  SALL4 expression in germ cell and non-germ cell tumors: a systematic immunohistochemical study of 3215 cases.

Authors:  Markku Miettinen; Zengfeng Wang; Peter A McCue; Maarit Sarlomo-Rikala; Janusz Rys; Wojciech Biernat; Jerzy Lasota; Yi-Shan Lee
Journal:  Am J Surg Pathol       Date:  2014-03       Impact factor: 6.394

8.  Ki-67 labeling index as an adjunct in the diagnosis of serous tubal intraepithelial carcinoma.

Authors:  Elisabetta Kuhn; Robert J Kurman; Ann Smith Sehdev; Ie-Ming Shih
Journal:  Int J Gynecol Pathol       Date:  2012-09       Impact factor: 2.762

9.  Detection of serous precursor lesions in resected fallopian tubes from patients with benign diseases and a relatively low risk for ovarian cancer.

Authors:  Naoyo Nishida; Fumihiro Murakami; Koichi Higaki
Journal:  Pathol Int       Date:  2016-06       Impact factor: 2.534

10.  An Immunohistochemical Algorithm for Ovarian Carcinoma Typing.

Authors:  Martin Köbel; Kurosh Rahimi; Peter F Rambau; Christopher Naugler; Cécile Le Page; Liliane Meunier; Manon de Ladurantaye; Sandra Lee; Samuel Leung; Ellen L Goode; Susan J Ramus; Joseph W Carlson; Xiaodong Li; Carol A Ewanowich; Linda E Kelemen; Barbara Vanderhyden; Diane Provencher; David Huntsman; Cheng-Han Lee; C Blake Gilks; Anne-Marie Mes Masson
Journal:  Int J Gynecol Pathol       Date:  2016-09       Impact factor: 2.762

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.